In a filing, Biodesix Inc revealed its President & CEO Hutton Scott unloaded Company’s shares for reported $49455.0 on Feb 12 ’24. In the deal valued at $1.66 per share,29,708 shares were sold. As a result of this transaction, Hutton Scott now holds 465,011 shares worth roughly $0.59 million.
Then, Cowie Robin Harper sold 8,699 shares, generating $14,481 in total proceeds. Upon selling the shares at $1.66, the CFO, Sec’y & Treasurer now owns 169,410 shares.
Before that, O’Kane Kieran sold 5,412 shares. Biodesix Inc shares valued at $9,009 were divested by the Chief Commercial Officer at a price of $1.66 per share. As a result of the transaction, O’Kane Kieran now holds 68,005 shares, worth roughly $86366.35.
Morgan Stanley downgraded its Biodesix Inc [BDSX] rating to an Equal-weight from a an Overweight in a research note published on November 17, 2021; the price target was decreased to $11 from $21. A number of analysts have revised their coverage, including William Blair’s analysts, who began to cover the stock in late November with a ‘”an Outperform”‘ rating. Morgan Stanley began covering BDSX with “an Overweight” recommendation on November 23, 2020. Canaccord Genuity started covering the stock on November 23, 2020. It rated BDSX as “a Buy”.
Price Performance Review of BDSX
On Tuesday, Biodesix Inc [NASDAQ:BDSX] saw its stock fall -9.93% to $1.27. Over the last five days, the stock has lost -14.77%. Biodesix Inc shares have fallen nearly -30.98% since the year began. Nevertheless, the stocks have fallen -26.16% over the past one year. While a 52-week high of $2.21 was reached on 02/05/24, a 52-week low of $1.03 was recorded on 04/09/24. SMA at 50 days reached $1.5881, while 200 days put it at $1.5394. A total of 0.81 million shares were traded, compared to the trading of 49600.0 shares in the previous session.
Levels Of Support And Resistance For BDSX Stock
The 24-hour chart illustrates a support level at 1.1733, which if violated will result in even more drops to 1.0767. On the upside, there is a resistance level at 1.4033. A further resistance level may holdings at 1.5367. The Relative Strength Index (RSI) on the 14-day chart is 33.91, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0643, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 82.35%. Stochastics %K at 42.34% indicates the stock is a holding.
How much short interest is there in Biodesix Inc?
A steep rise in short interest was recorded in Biodesix Inc stocks on Mar 15, 2024, growing by 11050.0 shares to a total of 0.18 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 0.17 million shares. There was a rise of 6.1%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 0.37% of the overall stock float, the days-to-cover ratio (short ratio) rose to 2.12.
The most recent change occurred on November 23, 2020 when BTIG Research began covering the stock and recommended ‘”a Buy”‘ rating along with a $22 price target.
